Npil Pharmaceuticals (UK) Limited
Records under this name other than patents Npil Pharmaceuticals (UK) Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Npil Pharmaceuticals (UK) Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,501,829 | Compounds for use as ligands Formerly held Lapsed on the fee record Ended Aug 6, 2021 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2021 | USPTO record |
| US 6,372,931 | Transfer hydrogenation process and catalyst Term ended Term ended Nov 9, 2019 · USPTO record | Term ended | Term ended Nov 9, 2019 | USPTO record |
| US 9,024,025 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended May 5, 2019 · USPTO record | Lapsed on the fee record | Ended May 5, 2019 | USPTO record |
| US 8,865,924 | Compounds for use as ligands Formerly held Lapsed on the fee record Ended Oct 21, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2018 | USPTO record |
| US 8,703,945 | Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin Formerly held Lapsed on the fee record Ended Apr 22, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 22, 2018 | USPTO record |
| US 6,545,188 | Transfer hydrogenation process and catalyst Term ended Term ended Mar 20, 2018 · USPTO record | Term ended | Term ended Mar 20, 2018 | USPTO record |
| US 8,614,335 | Process and intermediates useful in the preparation of statins, particularly atorvastatin Formerly held Lapsed on the fee record Ended Dec 24, 2017 · USPTO record | Lapsed on the fee record | Ended Dec 24, 2017 | USPTO record |
| US 8,278,467 | Process and intermediate compounds useful in the preparation of statins Formerly held Lapsed on the fee record Ended Oct 2, 2016 · USPTO record | Lapsed on the fee record | Ended Oct 2, 2016 | USPTO record |
| US 7,414,141 | Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin Formerly held Lapsed on the fee record Ended Aug 19, 2016 · USPTO record | Lapsed on the fee record | Ended Aug 19, 2016 | USPTO record |
| US 7,462,731 | Processes for the preparation of heterocyclic hydroxyamines and intermediates and catalysts for use therein Lapsed on the fee record Ended Dec 9, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 9, 2012 | USPTO record |